Preimplantation Genetic Testing of Embryos (PGT) in Ukraine

Preimplantation genetic testing (PGT) is the analysis of a few cells from an embryo created in an IVF programme, carried out before transfer to the uterus. There are three types: PGT-M looks for a specific inherited disease known in the family, PGT-SR checks for the consequences of a chromosomal rearrangement in one of the parents, and PGT-A counts the number of chromosomes. The first two have clear indications. The benefit of PGT-A for most patients has not been proven, and ESHRE advises against offering it to everyone. We explain how trophectoderm biopsy is done, what a mosaic result means, what makes up the cost and what to check with the clinic before the programme starts.
Request a consultation
AnaesthesiaNot needed for the test itself; egg retrieval is usually done under sedation
DurationUsually several weeks for results after the biopsy
Hospital stayOutpatient
RecoveryUsually a few days after egg retrieval

What PGT is and who needs it

PGT (preimplantation genetic testing) is a genetic analysis of an embryo created in an IVF programme, carried out before the embryo is transferred to the uterus. The embryologist takes a few cells from the outer layer of the blastocyst, a genetics laboratory analyses them, and based on the result the doctor and the couple decide which embryo to transfer. This field used to be called PGD and PGS; current international terminology brings it all together under the name PGT and divides it into three types.

PGT-M looks for a monogenic inherited disease, that is, one caused by a single gene, whose mutation has already been identified in the family: cystic fibrosis, spinal muscular atrophy, thalassaemia, Huntington's disease and others. PGT-SR is needed when one of the partners has a balanced chromosomal rearrangement, such as a translocation or an inversion: the person is healthy, but some of their embryos receive an unbalanced set of genetic material. PGT-A checks whether the embryo has the correct number of chromosomes, that is, it looks for aneuploidies.

The three types differ greatly in their evidence base. PGT-M and PGT-SR have a clear aim: to avoid passing a disease known in the family on to the child, or to reduce the number of miscarriages caused by a rearrangement. PGT-A is more complicated. It does not make embryos healthier, it only sorts those that already exist, and large randomised trials have not shown that it increases the chance of having a baby for most couples. In its 2023 recommendations on add-ons in reproductive medicine, ESHRE advises against using PGT-A routinely.

One more limit: PGT does not check an embryo "for everything" and does not replace tests during pregnancy. The test answers only the question it has been set up for, so before the programme it is worth stating clearly what question you as a couple are asking.

Doctor consulting a patient in a clinic room
Why MediUkraine?
Your personal care
coordinator at MediUkraine
Contact the MediUkraine team

Coming to Ukraine for fertility treatment: what to expect

Travel. Ukrainian airspace is closed, so there are no commercial flights. Patients usually arrive overland from a neighbouring EU country, by car, bus or train.

Visas. Citizens of the EU, the United Kingdom and the United States do not need a visa for short stays in Ukraine. Rules depend on your citizenship, so check your own before booking.

Safety, plainly. Ukraine is at war. Air raid alerts occur across the country, and a procedure can be rescheduled because of one. Several governments advise against travel to Ukraine, and while that advice stands, ordinary travel and medical insurance is often void — confirm your cover with your insurer before you commit to anything. It is also worth asking the clinic how its laboratory and embryo storage are protected during power outages.

Language. MediUkraine handles correspondence with you in English. Ask the clinic which languages its doctors and coordinators use with international patients.

Payment. You pay the clinic directly. Our service is free of charge for you.

More on travel, safety and insurance: Safety and travel.

When PGT makes sense and when the evidence is thin

One or both partners carry a known inherited mutation.
One of the partners carries a balanced translocation or inversion.
Older maternal age is a reason to discuss PGT-A, but not an automatic indication.
Recurrent implantation failure and recurrent miscarriage with no known cause are a disputed indication.

How to prepare for PGT

  1. Start with a consultation with a geneticist, not with choosing a laboratory.
  2. For PGT-M and PGT-SR you will need documents confirming the diagnosis in the family: a genetic test report giving the exact name of the gene and variant, or a karyotype describing the rearrangement.
  3. The woman has the usual work-up before IVF.
  4. Agree in advance what to do with ambiguous results.

Biopsy, types of PGT and analysis technologies

Trophectoderm biopsy. Today the standard is biopsy at the blastocyst stage, most often on day 5–6 of development. The blastocyst already has two types of cells: the inner cell mass, which develops into the fetus, and the trophectoderm, which forms the placenta. Under a microscope, using a laser and micro-instruments, the embryologist separates a few trophectoderm cells, usually 5 to 10, without touching the inner cell mass. Most laboratories have abandoned biopsy on day 3, when the embryo has about eight cells: in a randomised trial it reduced the chance of implantation, whereas no such effect was found for trophectoderm biopsy.

After the biopsy the embryo is vitrified and stored while the laboratory analyses the sample. That is why PGT usually means a "freeze-all" strategy: the transfer is done in a later cycle, once the results are known. A few cells contain very little DNA, so before analysis it is multiplied by whole-genome amplification.

PGT-A and NGS. The main technology for PGT-A is next-generation sequencing (NGS). It counts the copies of each chromosome and shows whether there is an extra or a missing chromosome, as in Down syndrome (trisomy 21), as well as large losses or duplications of chromosome segments. Some platforms, for example those based on SNP microarrays, can additionally detect changes that standard NGS does not see, including triploidy; what exactly the test can see depends on the laboratory's specific platform. The old FISH method, which checked only a few chromosomes, is considered obsolete. What PGT-A does not see: monogenic diseases and small deletions or duplications below the resolution of the method.

PGT-M. Here the laboratory looks for a specific gene variant. There is little DNA, and during amplification one of the two copies of the gene is sometimes "lost", so reliable approaches do not rely on direct detection of the mutation alone. Alongside it, neighbouring genetic markers are analysed that are inherited together with the affected or the healthy copy of the gene. This is why the DNA of the partners and relatives is needed. Many laboratories also check the number of chromosomes in parallel during PGT-M, but this is a separate decision worth discussing with the geneticist.

PGT-SR. For carriers of translocations and inversions, the analysis shows whether the embryo has received a complete set of genetic material from the rearranged chromosomes. What the method can detect depends on the size of the segments that have changed place: NGS may miss very small fragments, so before the cycle the laboratory assesses whether the test is suitable for your rearrangement. An embryo carrying a balanced rearrangement can be told apart from an embryo with a normal karyotype only by special methods, which not every laboratory has.

Mosaicism. Some embryos contain cells with different sets of chromosomes. A biopsy takes a few cells from one spot of the trophectoderm, and a "mosaic" finding means only that normal and abnormal cells are mixed in that sample. The biopsy cannot show with certainty what is happening in the inner cell mass. Such embryos used to be simply discarded. Data have now accumulated on healthy babies born after the transfer of mosaic embryos, and the Preimplantation Genetic Diagnosis International Society (PGDIS) and ESHRE acknowledge in their position statements that mosaic embryos should not all be discarded automatically.

At the same time, a mosaic embryo on average has a lower chance of implantation and a higher risk of miscarriage than an embryo with no abnormalities detected, and how the proportion of abnormal cells and the chromosome affected influence the outlook has not yet been studied well enough. Mosaic embryos are therefore usually considered for transfer when there are no embryos without abnormalities, after a consultation with a geneticist and with prenatal diagnosis during the pregnancy. Different laboratories set different thresholds above which a sample is considered mosaic, so the same embryo could have received a different finding in another laboratory.

What is not offered here. MediUkraine does not offer selection of the baby's sex without medical indications. The sex of an embryo is determined only for medical reasons, to prevent sex-linked inherited diseases, and in that case it is part of PGT-M at the geneticist's decision rather than a separate service.

What patients from abroad should know

  • The biopsy is done by the clinic's embryologists, while the genetic analysis is often performed by a separate laboratory.
  • The preparatory part can be started remotely.
  • As a rule, a programme with PGT needs two trips.
  • The partner does not have to be there the whole time.
  • After the biopsy the embryos are stored at the clinic until transfer, so it is worth finding out the storage terms straight away.
  • Rules on PGT differ from country to country, and what is permitted in one may be restricted in another.

After the biopsy: results and next steps

For the woman, the biopsy itself goes unnoticed: it is done in the laboratory on embryos already obtained. How you feel after egg retrieval is the same as in a regular IVF cycle: for a few days there may be a pulling sensation in the lower abdomen, bloating and light spotting. Severe pain, a noticeably swollen abdomen, shortness of breath or passing less urine are reasons to see a doctor straight away: these are possible signs of ovarian hyperstimulation syndrome.

The laboratory usually sends the results within a few weeks of the biopsy; the exact timing is worth checking in advance. In the report each embryo receives a finding: no abnormalities detected (euploid), aneuploid, mosaic, or no result if the DNA could not be analysed. For PGT-M the report also states whether the embryo has inherited the mutation.

Several scenarios are then possible. If there are suitable embryos, a frozen embryo transfer is planned: the endometrium is prepared in a natural or hormonally prepared cycle and, as a rule, transferring a single embryo is advised. If there are no suitable embryos, the doctor discusses the options: another stimulation cycle, repeat biopsy of embryos with no result, transfer of a mosaic embryo after a consultation with a geneticist, or other routes to pregnancy.

PGT does not replace tests during pregnancy. After PGT-M, ESHRE advises considering prenatal diagnosis, for example chorionic villus sampling or amniocentesis, to confirm the result. After PGT-A, and especially after the transfer of a mosaic embryo, it is worth discussing with the doctor which screening or diagnostic tests to have and at what stage.

How PGT works, step by step

Step 1. Consultation with a fertility specialist and a geneticist. The doctors review the couple's history, test results and genetic reports, establish what question the test has to answer and honestly assess whether PGT will be of benefit in your particular situation.

Step 2. Test preparation. For PGT-M, and often for PGT-SR, the laboratory builds an individual analysis system from the DNA of the partners and, if needed, relatives. PGT-A needs no separate preparation.

Step 8. Pregnancy test and follow-up. The hCG blood test is taken on the day set by the clinic. Once a pregnancy is established, prenatal tests are planned, and after PGT-M confirmation of the result is discussed.

What makes up the cost and what to ask the clinic

The quote for a programme with PGT usually includes consultations with the fertility specialist and the geneticist, pre-IVF tests, stimulation medication, egg retrieval with sedation, fertilisation by ICSI, culture to the blastocyst stage, biopsy, genetic analysis of each embryo, vitrification, storage and frozen embryo transfer. For PGT-M and PGT-SR, the one-off preparation of an individual test is added to this.

Some of the costs nobody knows in advance: how many blastocysts there will be, how many of them will get a result and whether a second cycle will be needed. It is therefore useful to ask for a quote in two versions, for example for two and for five embryos tested, and to find out separately what you pay if no embryo survives to the blastocyst stage.

What to ask the clinic before you start. Which laboratory does the analysis, with which technology, and how long the wait for the report is. Whether the laboratory reports mosaicism and from what threshold. What proportion of its samples come back with no result and how much a repeat biopsy costs. Which geneticist will explain the results and whether that consultation is included in the quote. How embryo storage is paid for after the first year.

Also ask what the clinic does if all the embryos turn out to be aneuploid: whether there is a consultation with a plan for next steps and whether tests already done are taken into account in a new cycle. These answers matter more than the overall total, because they show what the whole path to a transfer may cost, not just one stage.

The clinic gives the exact cost and plan after a consultation. MediUkraine will pass on your request and documents to a fertility clinic, and the clinic will prepare a treatment plan and a quote before your trip.

Risks, limitations and safety

Risks of the IVF programme. PGT adds no physical risks for the woman beyond those of a regular IVF cycle, because the biopsy is done on embryos in the laboratory. The main risks relate to stimulation and egg retrieval: ovarian hyperstimulation syndrome and, rarely, bleeding, infection or injury to nearby organs, or a reaction to sedation. The "freeze-all" strategy usually used with PGT reduces the risk of severe hyperstimulation, because no pregnancy occurs in that cycle.

Effect of the biopsy on the embryo. In studies, trophectoderm biopsy performed by an experienced embryologist did not reduce the chance of implantation. There is still little long-term follow-up of the health of children born after PGT, so no firm conclusions can be drawn about long-term effects. Each additional thaw and repeat biopsy slightly raises the risk that the embryo will not survive the procedure.

Diagnostic errors. A false positive result means that a viable embryo was judged abnormal and not transferred. A false negative result is also possible. The causes are mosaicism, the loss of one copy of the gene during amplification and contamination of the sample with someone else's DNA. That is exactly why prenatal diagnosis is advised after PGT-M.

There may be no suitable embryo at all. Especially in older women or those with a low reserve, all the embryos may be reported as "aneuploid". This is emotionally hard, but it also provides information for the next decision. It is worth knowing the other side too: when there are few embryos, PGT-A can reduce the chance of a baby if an embryo that could have developed is discarded because of a mosaic or false result.

Limits of the method. PGT answers only the question it was set. An embryo with no abnormalities detected guarantees neither a pregnancy nor the child's health with respect to other conditions: the general population risk of congenital anomalies and of diseases the test did not look for remains. An honest clinic discusses this before the consent form is signed, not after.

Related services

Frequently asked questions

Does everyone having IVF need PGT-A?

No. PGT-A does not make embryos better, it only selects among those already there. Large randomised trials have not shown that it raises the chance of having a baby from one stimulation cycle for most couples, and in its 2023 recommendations ESHRE advises against using it routinely.

Discussing the test makes sense for older women with several blastocysts, when a single embryo has to be chosen for transfer. PGT-M and PGT-SR are a different situation: where a mutation or chromosomal rearrangement is known in the family, they have clear indications.

How much does PGT cost in Ukraine?

There is no single figure, because the cost is made up of the IVF programme and the genetic analysis, which is usually charged per embryo tested. For PGT-M, and often for PGT-SR, a one-off preparation of an individual test is added. Biopsy, vitrification, storage and frozen embryo transfer are paid for separately.

The clinic gives the exact cost and plan after a consultation and a review of your documents. MediUkraine can help you find a fertility clinic, and the clinic will prepare a quote before your trip.

Does PGT increase the chances of pregnancy?

The chances depend primarily on the woman's age and the number of embryos; PGT only helps to sort them. PGT-A can help choose an embryo for transfer and, for some patients, reduce the number of failed attempts, but the test does not increase the overall chance of a baby from all the embryos of one cycle, because it does not create new healthy embryos.

For PGT-M and PGT-SR the main aim is different: to avoid passing a known disease on to the child, or to reduce the risk of miscarriage caused by a chromosomal rearrangement.

Does the biopsy harm the embryo?

The biopsy is done at the blastocyst stage and takes a few cells of the trophectoderm, which forms the placenta rather than the fetus. In studies, trophectoderm biopsy performed by an experienced embryologist did not reduce the chance of implantation, unlike the old biopsy on day 3.

The risk grows with each additional thaw and repeat biopsy, so these are done only when needed. There is still little long-term follow-up of the health of children born after PGT.

What should we do if an embryo is mosaic?

Do not rush to discard it. A mosaic result means that normal and abnormal cells are mixed among the few cells of the sample, while the biopsy cannot show with certainty what is happening in the embryo itself. Healthy babies have been born after the transfer of mosaic embryos, and PGDIS and ESHRE acknowledge that such embryos should not all be discarded automatically.

At the same time, their chance of implantation is lower and their risk of miscarriage higher than for embryos without abnormalities. The decision is made after a consultation with a geneticist, taking into account which chromosome is affected, and with prenatal diagnosis during the pregnancy.

Does PGT replace tests during pregnancy?

No. PGT examines a few trophectoderm cells, and only for what the test has been set up to find. After PGT-M, ESHRE advises considering prenatal diagnosis, for example chorionic villus sampling or amniocentesis.

After PGT-A, and especially after the transfer of a mosaic embryo, the screening or diagnostic plan is worth discussing with the doctor managing the pregnancy. Routine pregnancy checks, such as ultrasound scans at the set times, go ahead just as they would without PGT.

How long do the results take and when is the transfer?

The genetics laboratory's report usually arrives within a few weeks of the biopsy; the exact timing depends on the laboratory and the type of test. Throughout this time the embryos are kept frozen.

The transfer is done in the next or one of the following cycles after the endometrium has been prepared, so at least one menstrual cycle usually passes between egg retrieval and transfer. For PGT-M, add the time needed to prepare the individual test before stimulation.

Planning IVF in Ukraine?

Tell us about your situation: we will find a fertility clinic and pass on your request. The clinic will give you a treatment plan and a quote after the consultation.

Request a consultation →
Request a consultation